MENU
CURE
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

CURE stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Health Care Select Sector Index... Show more

Category: #Trading
CURE
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for CURE with price predictions
Jul 31, 2026

CURE's RSI Oscillator leaves overbought zone

The 10-day RSI Indicator for CURE moved out of overbought territory on July 29, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 instances where the indicator moved out of the overbought zone. In of the 27 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 66 cases where CURE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CURE turned negative on July 31, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CURE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CURE broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 24, 2026. You may want to consider a long position or call options on CURE as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for CURE moved above the 200-day moving average on July 22, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CURE advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 237 cases where CURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Abbott Laboratories (NYSE:ABT), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY).

Industry description

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Health Care Select Sector Index. The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology. It is non-diversified.

Market Cap

The average market capitalization across the Direxion Daily Healthcare Bull 3X ETF ETF is 96.65B. The market cap for tickers in the group ranges from 9.77B to 1.02T. LLY holds the highest valuation in this group at 1.02T. The lowest valued company is HSIC at 9.77B.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily Healthcare Bull 3X ETF ETF was -0%. For the same ETF, the average monthly price growth was 4%, and the average quarterly price growth was 9%. BAX experienced the highest price growth at 17%, while HUM experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Direxion Daily Healthcare Bull 3X ETF ETF was 18%. For the same stocks of the ETF, the average monthly volume growth was -9% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 40
P/E Growth Rating: 43
Price Growth Rating: 34
SMR Rating: 58
Profit Risk Rating: 76
Seasonality Score: -32 (-100 ... +100)
View a ticker or compare two or three
CURE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/
CURE's RSI Oscillator leaves overbought zone